Reaction
Sweat Gland Tumour reporting signals
As of the last recalculation, Sweat Gland Tumour appears in 232 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 78.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Busulfan | 13 | 78.5 | 78.5 |
| Etoposide | 44 | 66.0 | 66.1 |
| Ranolazine | 6 | 52.9 | 52.9 |